Trials / Completed
CompletedNCT04651400
Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection
Multinational, Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- Octapharma · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
Multicentre, multinational, non-interventional, observational, retrospective, patient record study to evaluate changes in coagulation parameters in patients with severe COVID-19 infection receiving/not treatment with antithrombin (AT) III
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Antithrombin III | Antithrombin III |
Timeline
- Start date
- 2020-10-19
- Primary completion
- 2022-09-27
- Completion
- 2022-09-27
- First posted
- 2020-12-03
- Last updated
- 2023-10-10
Locations
6 sites across 4 countries: Austria, France, Germany, Sweden
Source: ClinicalTrials.gov record NCT04651400. Inclusion in this directory is not an endorsement.